Associated Papers
Variability in proliferative and migratory defects in Hirschsprung disease-associated RET pathogenic variants.
Fries LE et al.
American Journal of Human Genetics, 2025
Variability in proliferative and migratory defects in Hirschsprung disease-associated RET pathogenic variants.
Fries LE et al.
Biorxiv : the Preprint Server for Biology, 2024
Looking for RET alterations in thyroid cancer: clinical relevance, methodology and timing.
Elisei R et al.
Endocrine, 2023
[Intestinal ganglioneuromatosis as an early extra-endocrine manifestation of type 2B multiple endocrine neoplasia].
Averianova JV et al.
Problemy Endokrinologii, 2023
Biallelic germline mutations in MAD1L1 induce a syndrome of aneuploidy with high tumor susceptibility.
Villarroya-Beltri C et al.
Science Advances, 2022
Comprehensive Assessment of Indian Variations in the Druggable Kinome Landscape Highlights Distinct Insights at the Sequence, Structure and Pharmacogenomic Stratum.
Panda G et al.
Frontiers in Pharmacology, 2022
Identification of a novel variant of the RET proto-oncogene in a novel family with Hirschsprung's disease.
Kawano T et al.
Pediatric Surgery International, 2017
[Hereditary thyroid carcinoma and its molecular diagnostics].
Dvořáková S et al.
Ceskoslovenska Patologie, 2014
In silico profiling and structural insights of missense mutations in RET protein kinase domain by molecular dynamics and docking approach.
George Priya Doss C et al.
Molecular Biosystems, 2014
Consensus: a framework for evaluation of uncertain gene variants in laboratory test reporting.
Crockett DK et al.
Genome Medicine, 2012
Orolabial signs are important clues for diagnosis of the rare endocrine syndrome MEN 2B. Presentation of two unrelated cases.
Sallai A et al.
European Journal of Pediatrics, 2008
Molecular diagnosis of primary hyperparathyroidism in familial cancer syndromes.
Marsh DJ et al.
Expert Opinion on Medical Diagnostics, 2007
RET proto-oncogene genotyping using unlabeled probes, the masking technique, and amplicon high-resolution melting analysis.
Margraf RL et al.
The Journal of Molecular Diagnostics : Jmd, 2007
[Thyroid carcinomas and Hirschsprung's disease--10-year experience with molecular genetic testing of the RET proto-oncogene].
Bendlová B et al.
Vnitrni Lekarstvi, 2006
Genetic analyses of apparently sporadic pheochromocytomas: the Rotterdam experience.
Korpershoek E et al.
Annals of the New York Academy of Sciences, 2006
New multiple somatic mutations in the RET proto-oncogene associated with a sporadic medullary thyroid carcinoma.
Dvoráková S et al.
Thyroid : Official Journal of the American Thyroid Association, 2006
Impact of RET proto-oncogene analysis on the clinical management of multiple endocrine neoplasia type 2.
Toledo SP et al.
Clinics (sao Paulo, Brazil), 2006
[Genetic screening of multiple endocrine neoplasia type 2: experience of the USP Endocrine Genetics Unit].
Santos MA et al.
Arquivos Brasileiros De Endocrinologia E Metabologia, 2006
Three novel mutations in the RET proto-oncogene.
Kalinin VN et al.
Journal of Molecular Medicine (berlin, Germany), 2001